Over the course of 40 years, the management of HIV has drastically changed. A wide variety of medications and data shape the current treatment of HIV. However, pockets of people with HIV still remain with barriers to successful outcomes, such as those with low-level viraemia and the highly treatment experienced. Transitions of care become critical for specific populations to ensure access and treatment are available. Comorbidities such as dyslipidaemia also impact outcomes. Looking forward, injectable medications will become more available to all people with HIV as injectable programmes are integrated into usual care and more injectable options are available.

HIV: how to manage low-level viraemia in people living with HIV

Emily K Hanners, Jessica Benitez-Burke, Melissa E Badowski

Article Type

Review

Published

This is a narrative review of the growing evidence of low-level viraemia in people living with HIV to determine risk factors and antiretroviral therapy management strategies and to discuss the implications of low-level viraemia on the development of future virological failure.

Read more

HIV: how to manage heavily treatment-experienced patients

Stephanie Spivack, Stephen Pagkalinawan, Rafik Samuel, David E Koren

Article Type

Review

Published

This narrative review provides an overview of the clinician approach to care, including diagnostics, approaches to regimen creation, relevant resources, and a broad array of
both currently available and upcoming antiretrovirals that may be used in regimens for heavily treatment-experienced patients.

Read more

Register for alerts

I would like to be contacted by Drugs in Context when new articles are posted.